BIOTISSUE's CryoTek Method: Mechanism of Action

Show Description +

BIOTISSUE's proprietary CryoTek processing method preserves the active extracellular matrix (ECM) components of the amniotic membrane, including heavy chain hyaluronic acid, PTX 3 [HC-HA activator], collagens (types I, III, IV, V, and VI), fibronectin, laminin, proteoglycans, and growth factors. BIOTISSUE's CryoTek products retain key components responsible for regenerative wound healing.

Posted: 12/17/2012

Keywords:

Bio-Tissue

•

Cornea

•

Corneal Disease

BIOTISSUE's CryoTek Method: Mechanism of Action

BIOTISSUE's proprietary CryoTek processing method preserves the active extracellular matrix (ECM) components of the amniotic membrane, including heavy chain hyaluronic acid, PTX 3 [HC-HA activator], collagens (types I, III, IV, V, and VI), fibronectin, laminin, proteoglycans, and growth factors. BIOTISSUE's CryoTek products retain key components responsible for regenerative wound healing.

Posted: 12/17/2012

Keywords:

Bio-Tissue

•

Cornea

•

Corneal Disease

Please log in to leave a comment.

More in Cornea

Going on Offense With Epioxa

Brandon D. Ayres, MD; Parag A. Majmudar, MD; and Neel S. Vaidya, MD, MPH, MBA

Innovations in Amniotic Membranes: A New Offering in the Space

I. Paul Singh, MD; and Neel R. Desai, MD

Refractory Pupillary Block

Ariana Levin, MD; Sefy Paulose, MD; and Vaidehi Dedania, MD